02.08.2025 • News
Merck Sells Pigments Business to GNMI
Merck transferred its Surface Solutions business to Global New Material International (GNMI), one of the largest manufacturers of pearlescent pigments.
Mergers & Acquisitions (M&A)
Ofichem Acquires Meribel Pharma Solutions’ Uppsala Site
Ofichem, a European CDMO specialising in high-quality active pharmaceutical ingredients (APIs) and integrated drug development and manufacturing services, has acquired Meribel Pharma Solutions’ site in Uppsala, Sweden.
24.07.2025 • News
Bakelite Acquires Sestec to Boost Bio-based Adhesives Offering
Bakelite has successfully acquired Sestec, a Poland-based company, for its sustainable protein-based adhesives for wood and composite products.
21.07.2025 • News
Harke Acquires Swedish Vendico
Harke Group, based in Mülheim an der Ruhr, Germany, acquired the Swedish Vendico Group, comprising Vendico Chemical, Inventicon, and Omni International.
MSD to Acquire Verona Pharma for $10 Billion
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
09.07.2025 • News
Azelis Acquires Italian Specialty Chemicals Distributor ACEF
Azelis has acquired Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic, and pharma industries in Italy.
08.07.2025 • News
Bio-Rad Acquires Stilla Technologies
Bio-Rad Laboratories, a life science research and clinical diagnostics company, has completed the acquisition of Stilla Technologies, a developer of digital PCR (dPCR) systems.
AbbVie to Acquire Capstan Therapeutics for $2 Billion
AbbVie has announced it will acquire Capstan Therapeutics, a clinical-stage biotechnology company focused on advancing in vivo cell engineering through RNA delivery using targeted lipid nanoparticles (tLNPs).
02.07.2025 • News
BASF Completes Acquisition of DOMO Chemicals' Shares in Alsachimie JV
BASF has acquired DOMO Chemicals' 49% stake in the Alsachimie joint venture and is now the sole owner of the production company for essential precursors of polyamide (PA) 6.6, including KA oil, adipic acid and hexamethylenediamine adipate (AH salt) in Chalampé, France. The parties have agreed not to disclose financial details of the transaction.
30.06.2025 • News
IMCD Acquires Chilean Specialty Chemicals Distributor
IMCD has acquired Apus Química, a specialty chemicals distributor in Chile.
Sika Acquires Gulf Additive Factory
Sika has acquired Gulf Additive Factory in the State of Qatar. The company manufactures a wide range of construction chemical products.
AkzoNobel to Sell AkzoNobel India to JSW Group
AkzoNobel has signed an agreement to sell its shareholding in AkzoNobel to the JSW Group, one of India’s leading diversified conglomerates.
IMCD Acquires Indian Pharma Supplier Trichem
IMCD, a global partner for the distribution and formulation of speciality chemicals and ingredients, has acquired Trichem, an Indian pharmaceutical supplier.
12.06.2025 • News
Aditya Birla Acquires Cargill Specialty Chemicals Facility
Aditya Birla, an Indian multinational conglomerate, recently announced the expansion of its US Advanced Materials business with the acquisition of Cargill’s specialty chemical facility in Dalton, Georgia.
Brenntag Specialties Acquires Mcepharma
Brenntag recently announced the acquisition of Mcepharma to strengthen Brenntag’s capabilities across the entire pharmaceutical and biopharmaceutical value chain.
Dow Sells its 50% Ownership in DowAksa
Dow announced that it has signed a sale and purchase agreement to sell its 50% interest in DowAksa to Aksa Akrilik Kimya Sanayii A.Ş., a company of Akkök Holding.
Sanofi to Acquire Blueprint Medicines
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology.
02.06.2025 • News
BASF to Acquire Shares in Alsachimie
BASF and DOMO Chemicals have signed an agreement giving BASF the right to acquire DOMO Chemicals' 49% stake in the Alsachimie joint venture, in which BASF currently holds 51%.
Sanofi to Acquire Vigil Neuroscience
Sanofi to acquire Vigil Neuroscience, a clinical-stage biotech focused on therapies for neurodegenerative diseases.
Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
19.05.2025 • News
IMCD to Acquire Tecom Ingredients
IMCD has signed an agreement to acquire 100% of the shares in Tecom Ingredients.
16.05.2025 • News
Sojitz Acquires Majority Shares in Nippon A&L
Sojitz, Sumitomo Chemical, and Mitsui Chemicals have concluded a share purchase agreement in which Sojitz will acquire Nippon A&L.
PCI Pharma Services Acquires Ajinomoto Althea
PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.
Roquette Acquires IFF Pharma, Reorganizes into Two Business Groups
Roquette completes IFF Pharma Solutions acquisition and unveils new structure for global growth and innovation.
28.04.2025 • News
Merck to Acquire US Biopharma Company SpringWorks Therapeutics
Merck and biopharmaceutical company SpringWorks Therapeutics, have entered into a definitive agreement for Merck to acquire SpringWorks.
10.04.2025 • News
Strategic Value Partners and Blantyre Capital Acquire OQ Chemicals
Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.
03.04.2025 • News
HAS Acquires Cerbios-Pharma
HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).
02.04.2025 • News
Ineos Energy Acquires Oil & Gas Assets from CNOOC
The completion of the deal marks the third major investment by Ineos Energy in the USA in the past three years. It increases Ineos' capital spending on energy assets in the USA to above $3 billion.
11.03.2025 • News
Sun Pharma to Acquire Checkpoint Therapeutics
Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.
07.03.2025 • News
Rio Tinto Completes Acquisition of Arcadium Lithium
Rio Tinto has completed the $6.7 billion acquisition of Arcadium Lithium and is now the parent company of Arcadium Lithium, which will be renamed Rio Tinto Lithium and will also include the Rincon Lithium Project.
07.03.2025 • News
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million
Ireland’s Jazz Pharmaceuticals signed an agreement to acquire its compatriot Chimerix for approximately $935 million. The transaction is expected to close in the second quarter of 2025.
06.03.2025 • News
ADNOC and OMV to Create Global Polyolefins Group
OMV and ADNOC agreed to combine their Borealis and Borouge shareholdings into Borouge Group International. ADNOC has also signed a share purchase agreement with Nova Chemicals, an indirect wholly owned subsidiary of Mubadala Investment Company, to acquire 100% of Nova Chemicals for an enterprise value of $13.4 billion. In addition, ADNOC and OMV have agreed for Borouge Group International to take over Nova Chemicals after closing.
04.03.2025 • News
WE Soda Buys Soda Ash Producer Genesis Alkali
WE Soda has acquired Genesis Alkali (Alkali), the largest US-based producer of natural soda ash, from Genesis Energy in an all-cash transaction for $1.425 billion.
26.02.2025 • News
Granules India Buys Swiss CDMO Senn Chemicals
Indian pharmaceutical company Granules India has agreed to acquire Senn Chemicals, a Swiss-based contract development and manufacturing organization (CDMO) specializing in peptides. The closing of the deal, which is subject to certain conditions, is expected to occur in the first half of 2025. Financial details of the transaction were not disclosed.
21.02.2025 • News
Pritzker Private Capital Acquires Majority Stake in Americhem
US investment company Pritzker Private Capital (PPC) has agreed to acquire a majority stake in Americhem, a family-owned US manufacturer of custom color masterbatch, performance additive and engineered compound solutions.
Johnson Matthey
Camelot Management Consultants AG
Barentz
DCAT - Drug, Chemical & Associated Technologies Association
EuroAPI
Squire Sanders
DSM Pharmaceutical Products
SchüllerConsulting
Solvay
Universität Hohenheim - Institut für Lebensmitteltechnik
AstraZeneca
Jazz Pharmaceuticals, plc
PPG
H.Essers
Azelis Corporate Services NV
Air Liquide Deutschland GmbH
Nouryon
Honeywell International Inc.
EvaluatePharma
Royal DSM N.V.
Oxea
Novartis International AG
Solenis LLC
Ofichem Group
Rhodia Europe
F. Hoffmann-La Roche Ltd
Agilent Technologies Inc.
Honeywell GmbH
Accenture
Infraserv GmbH & Co. Höchst KG
Biogen Inc.
Dow Chemical Company
Aditya Birla Group
HAS Healthcare Advanced Synthesis SA
AbbVie Dt. GmbH & Co.KG
Emerson Automation Solutions
Maire Tecnimont SpA
Medera
H.B. Fuller Company
Cambrex Corporation
Arkema
Clariant International Ltd
Wacker Chemie
BASF SE
Immedica Pharma AB
Bayer AG
Alantra
CSL Behring GmbH
Trinseo LLC
Novo Nordisk A/S